Welcome to the Ups and Downs of the US Midterm Election Impact Seeing the Forest for the Trees It’s always a whirlwind when it comes to political elections, and the US midterm election is no exception. In the immediate aftermath, it can be difficult to gauge the true impact it will have on the world…
FRESHWORKS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS OF UPCOMING DEADLINE; Encourages Investors to Contact the Firm The Deadline is Approaching! Hey there fellow investors! If you have invested in Freshworks Inc. (NasdaqGS: FRSH), you might want to pay attention to this important reminder from ClaimsFiler. The deadline to file lead plaintiff applications in a securities class…
Growth of Plant-based Beverages Market Introduction The plant-based beverages market is on the rise, with the US market expected to grow at a CAGR of 5.7% by 2032 and the German market at a CAGR of 6.3%. Organic plant-based beverages are also gaining traction, estimated to surge at a growth rate of 7.2% by 2032….
Middlefield Banc Corp. Receives Shareholder Approval for Merger with Liberty Bancshares, Inc. MIDDLEFIELD, Ohio, Nov. 08, 2022 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (“Middlefield”, or the “Company”) (NASDAQ: MBCN), the bank holding company for The Middlefield Banking Company, announced today that the shareholders of Middlefield have voted to approve the proposed merger of Liberty Bancshares,…
Profire Energy to Present and Host Investor Meetings at the 14th Annual Southwest Conference on the Doing Business in the Energy Sector An Exciting Opportunity for Profire Energy Profire Energy, Inc. is making waves in the technology industry with their innovative solutions that enhance the efficiency, safety, and reliability of industrial combustion appliances. The company…
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 Safety and Dosage Escalation The poster presentation will include data on safety and dosage escalation of HCW9218, a TGF-β trap developed by HCW Biologics Inc. Throughout the Phase 1 clinical trial, researchers have closely…
LUMANITY EXPANDS U.S. LIFE SCIENCES CONSULTING CAPABILITY WITH THE ACQUISITION OF CLARION Enhanced strategic consulting capabilities supporting products throughout their lifecycles New York, November 8, 2022 – Lumanity, a global leader in accelerating and optimizing access to medical advances, announced the acquisition of Clarion Healthcare (“Clarion”), a Boston-based life science consultancy with a 20-year history….
Exciting News from Neuronascent Inc.! Neuronascent to Present Further NNI-362 Phase1a Data at CTAD 2022 for Alzheimer’s Disease ROCKVILLE, Md., Nov. 08, 2022 (GLOBE NEWSWIRE) — Neuronascent Inc., today announced its abstract entitled “Reduction of plasma p-Tau181 from a Phase 1a Randomized Trial of NNI-362 in a healthy aged population consistent with amelioration of tau…
